Dipharma Sa, based in Switzerland, is a pharmaceutical company.
One of their notable products is CARGLUMIC ACID, with a corresponding US DMF Number 39329.
Remarkably, this DMF maintains an Active status since its submission on February 06, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 06, 2024, and payment made on February 01, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II